跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
TADIM colistimethate sodium 1million IU powder for nebuliser solution vial
Approved
STANDARD
TADIM colistimethate sodium 1million IU powder for nebuliser solution vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2dd471ef5a756f9a
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
2dd471ef5a756f9a
Product Name
TADIM colistimethate sodium 1million IU powder for nebuliser solution vial
Artg Id
165709
Artg Name
TADIM colistimethate sodium 1million IU powder for nebuliser solution vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2011-02-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/082c1b02136e837ebc36363a5bf4182b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d3d6d054bccfa75c25cf7001806a997a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2dd471ef5a756f9a
Type
Standard
Back to TGA Approvals
TADIM colistimethate sodium 1million IU powder for nebuliser solution vial - TGA Drug Approval Details